We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

MarcoPolo Pharmaceuticals Announces a Positive Phase II-III Study in Partial Seizure Patients

Double-blind, placebo-controlled clinical study to evaluate the efficacy, safety and tolerability of VLB-01.
News

Sepsis Study Comparing Three Treatment Methods Shows Same Survival Rate

NIH-funded clinical trial tested specific protocols against usual high-level care.
News

Pioneering Human Protein Atlas Project Achieves a Major Milestone

Project leverages Luminex's xMAP® technology for biobank profiling research.
News

Natera Announces Launch of Panorama™ NIPT in Portugal and Thailand

Company announces two new partnerships to launch Panorama™ outside of the US.
News

MIT Chemists Devise Novel Way to Manufacture Peptide Drugs

New, fast synthetic method enables manufacture of peptides in hours, which could boost drug development.
News

UCL’s Novel Approach to Research in Biologically-Relevant Models

Cellectricon and UCL unite to present a webinar, March 27, 11am-12pm EDT.
News

CiToxLAB Appoints John C. Kapeghian as Senior Director of Toxicology

This appointment makes the Montreal site attractive to North American clients and boosts CiToxLAB’s expertise in preclinical development and regulatory affairs.
News

Scientists Slow Development of Alzheimer's Cell-Killing Plaques

Researchers have learned how to fix a cellular structure called the Golgi that becomes fragmented in Alzheimer's patients.
News

Bright Future for Protein Nanoprobes

Berkeley Lab researchers discover new rules for single-particle imaging with light-emitting nanocrystals.
News

Atopix Announces Positive Phase IIb Results for Once Daily OC459 in Asthma

Company has announced the results at the AAAAI Annual Meeting, USA on March 1st.
Advertisement